Vandetanib-induced photoallergic dermatitis: A case report
| dc.contributor.author | Esen, Mustafa | |
| dc.contributor.author | Akdeniz, Nadiye | |
| dc.contributor.author | An, İsa | |
| dc.contributor.author | Yüce, Gurbet Acar | |
| dc.date.accessioned | 2024-04-24T19:11:20Z | |
| dc.date.available | 2024-04-24T19:11:20Z | |
| dc.date.issued | 2018 | |
| dc.department | Dicle Üniversitesi | en_US |
| dc.description.abstract | Vandetanib is a multi-kinase inhibitor of epidermal growth factor receptor (EGFR),vascular endothelial growth factor (VEGFR). Most common dermatological side effectsinduced by vandetanib include papulopustular eruption, hand-foot syndrome, andhyperpigmentation.In this report, we present a case with metastatic medullar thyroid carcinoma whodeveloped vandetanib-induced photoallergic dermatitis. | en_US |
| dc.identifier.doi | 10.25000/acem.409592 | |
| dc.identifier.endpage | 96 | en_US |
| dc.identifier.issn | 2564-6567 | |
| dc.identifier.issue | 2 | en_US |
| dc.identifier.startpage | 94 | en_US |
| dc.identifier.trdizinid | 292880 | |
| dc.identifier.uri | https://doi.org/10.25000/acem.409592 | |
| dc.identifier.uri | https://search.trdizin.gov.tr/yayin/detay/292880 | |
| dc.identifier.uri | https://hdl.handle.net/11468/27925 | |
| dc.identifier.volume | 3 | en_US |
| dc.indekslendigikaynak | TR-Dizin | |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | Archives of Clinical and Experimental Medicine | |
| dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | Vandetanib-induced photoallergic dermatitis: A case report | en_US |
| dc.title | Vandetanib-induced photoallergic dermatitis: A case report | |
| dc.type | Article | en_US |
